Press

Releases

IGC Pharma to Present at LD Micro Invitational XIII

May 18, 2023

IGC Pharma to Present at LD Micro Invitational XIII

Related Posts

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two

April 16, 2024

IGC Pharma Adds Advisor in Artificial Intelligence

April 9, 2024

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock

March 26, 2024

CEO Update

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation in Its Ongoing Phase 2 Clinical Trial

April 25, 2024

IGC-AD1’S Interim Phase 2 Data Show A Reduction In Alzheimer’s Agitation At Week Two

April 17, 2024